Utama › Kanser Esofagus › California › Baldwin Park
Kajian klinikal Kanser Esofagus di Baldwin Park, CA
14 kajian untuk Kanser Esofagus sedang mencari peserta di lokasi dalam dan sekitar Baldwin Park (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Mengambil pesertaFasa 1
- City of Hope National Medical Center, Duarte · 4 mi jauh
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Mengambil pesertaFasa 2
- City of Hope - Duarte Cancer Center, Duarte · 4 mi jauh
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 2
- City of Hope, Duarte · 4 mi jauh
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Mengambil pesertaFasa 1
- City of Hope National Medical Center, Duarte · 4 mi jauh
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Mengambil pesertaFasa 1
- City of Hope, Duarte · 4 mi jauh
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Mengambil pesertaFasa 1
- City of Hope Cancer Center, Duarte · 4 mi jauh
Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.
Mengambil pesertaFasa 3
- City of Hope National Cancer Center, Duarte · 4 mi jauh
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Mengambil pesertaFasa 1
- City of Hope, Duarte · 4 mi jauh
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
Mengambil pesertaFasa 3
- Research Site, Duarte · 4 mi jauh
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
Mengambil pesertaFasa 1
- City of Hope National Medical Center /ID# 276272, Duarte · 4 mi jauh
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Mengambil peserta
- Beckman Research Institute of City of Hope, Duarte · 4 mi jauh
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- City of Hope, Duarte · 4 mi jauh
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Mengambil pesertaKajian pemerhatian
- Massive Bio SYNERGY-AI site, Duarte · 4 mi jauh
64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer
Mengambil pesertaFasa 1/2
- City of Hope, Duarte · 4 mi jauh
Kajian Kanser Esofagus di bandar lain
- Houston, TX36 kajian
- Boston, MA23 kajian
- New York City, NY22 kajian
- Nashville, TN19 kajian
- St. Louis, MO17 kajian
- Pittsburgh, PA15 kajian
- Los Angeles, CA15 kajian
- Grand Rapids, MI14 kajian
- Philadelphia, PA13 kajian
- San Antonio, TX12 kajian
- Rochester, MN11 kajian
- Arlington, VA11 kajian
Kajian lain di Baldwin Park
- Kanser Payudara44 kajian
- Leukemia Mieloid Akut40 kajian
- Kanser Kolorektal37 kajian
- Kanser Paru-paru Bukan Sel Kecil36 kajian
- Kanser (semua jenis)34 kajian
- Kanser Prostat30 kajian
- Kanser Metastatik30 kajian
- Sindrom Mielodisplastik26 kajian
- Kanser Ovari25 kajian
- Kanser Paru-paru24 kajian
- Mieloma Pelbagai23 kajian
- Kanser Perut22 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.